On the Determination of Molar Concentration of Plasmin and Plasmin Inhibitors. [PDF]
P. O. Ganrot +8 more
openaire +1 more source
Do Extracellular Vesicles and the Biochemical Microenvironment Contribute to Amyloid Transthyretin Cardiomyopathy? [PDF]
Franzini M, Greco F, Musetti V, Emdin M.
europepmc +1 more source
Acute Ischaemic Stroke: Therapeutic Targets and Key Modulators of the Fibrinolytic System and Clot Formation. [PDF]
Swarup O +3 more
europepmc +1 more source
Autologous <i>in vitreo</i> generated plasmin assisted vitrectomy in the pediatric population. [PDF]
Subramaniam P +5 more
europepmc +1 more source
Quantitative Proteomics of Plasma-Derived Extracellular Vesicles Reveals a Plasminogen-Centered Protein Network in Transthyretin Cardiac Amyloidosis. [PDF]
Zaroui A +14 more
europepmc +1 more source
Tenecteplase and other TNK formulations lose PAI-1 resistance in their 2-chain form: comparison with alteplase. [PDF]
Liu Z +13 more
europepmc +1 more source
Various plasmin preparations were tested for their suitability for use in the assay of ??2-antiplasmin in blood plasma by the immediate plasmin inhibition test.
Hoegee de Nobel, E. +3 more
core
Genetic and hemostatic characterization of PAI-1 deficiency and isolated hyperfibrinolysis: data from the RBiN study. [PDF]
Haisma B +6 more
europepmc +1 more source
Case Report: Thrombotic and haemorrhagic disseminated intravascular coagulation in COVID-19. [PDF]
Song J, Zeng J, Song X.
europepmc +1 more source
Novel Roles of Urokinase- and Tissue-Type Plasminogen Activators in Substance Use Disorders: A Narrative Review of Molecular Mechanisms and Translational Perspectives. [PDF]
Bahi A, Steele S.
europepmc +1 more source

